Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Up to 4x
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Gilead Sciences, Inc. (GILD) – Gilead Sciences, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Gilead Sciences (GILD) trades at $134.43, down 1.31% on the day, with a bullish technical signal from moving averages and strong fundamental profitability metrics including a 30.99% net income margin and 43.19% ROE. Recent positive developments include FDA accelerated approval for Hepcludex for chronic HDV and a CHMP positive opinion for Trodelvy in Europe, while the company continues to deliver earnings beats with three consecutive quarters above expectations.
The outlook remains positive with analyst consensus at 'Buy' and a $160.67 price target representing 19.5% upside. Key opportunities include pipeline expansion in oncology and inflammation through acquisitions like Tubulis, while risks involve execution challenges in the cell therapy franchise and increasing debt levels as net cash flow turned negative in 2025.
Read full analysis

Key Stats

  • Market Cap
    $166.90B
  • Sector
    Health
  • 3M Drawdown
    -14.85%
  • Enterprise Value
    $181.44B
  • Dividend Yield
    2.44%
  • Typical Hold Time
    94 days
$134.43
52W Low: $105.93
25 Jun 2025
52W High: $155.8
11 Feb 2026

Gilead Sciences, Inc. (GILD) is currently valued at a market capitalization of $166.90B, with an enterprise value of $181.44B. Over the past 52 weeks, Gilead Sciences, Inc. has traded between a low of $105.93 and a high of $155.8, highlighting its annual price range. Over the past three months, Gilead Sciences, Inc. has recorded a drawdown of -14.85%, reflecting recent price volatility. Gilead Sciences, Inc. offers a dividend yield of 2.44%, with the most recent dividend of $0.82 paid on 13 Mar 26. On average, investors hold Gilead Sciences, Inc. for approximately 94 days, indicating typical investor behavior on the platform.

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $166.90B
  • Sector
    Health
  • 3M Drawdown
    -14.85%
  • Enterprise Value
    $181.44B
  • Dividend Yield
    2.44%
  • Typical Hold Time
    94 days
$134.43
52W Low: $105.93
25 Jun 2025
52W High: $155.8
11 Feb 2026

Gilead Sciences, Inc. (GILD) is currently valued at a market capitalization of $166.90B, with an enterprise value of $181.44B. Over the past 52 weeks, Gilead Sciences, Inc. has traded between a low of $105.93 and a high of $155.8, highlighting its annual price range. Over the past three months, Gilead Sciences, Inc. has recorded a drawdown of -14.85%, reflecting recent price volatility. Gilead Sciences, Inc. offers a dividend yield of 2.44%, with the most recent dividend of $0.82 paid on 13 Mar 26. On average, investors hold Gilead Sciences, Inc. for approximately 94 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!